Literature DB >> 10967201

Angiotensin-(1-7): an update.

R A Santos1, M J Campagnole-Santos, S P Andrade.   

Abstract

The renin-angiotensin system is a major physiological regulator of arterial pressure and hydro-electrolyte balance. Evidence has now been accumulated that in addition to angiotensin (Ang) II other Ang peptides [Ang III, Ang IV and Ang-(1-7)], formed in the limited proteolysis processing of angiotensinogen, are importantly involved in mediating several actions of the RAS. In this article we will review our knowledge of the biological actions of Ang-(1-7) with focus on the puzzling aspects of the mediation of its effects and the interaction Ang-(1-7)-kinins. In addition, we will attempt to summarize the evidence that Ang-(1-7) takes an important part of the mechanisms aimed to counteract the vasoconstrictor and proliferative effects of Ang II.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10967201     DOI: 10.1016/s0167-0115(00)00138-5

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  75 in total

1.  Angiotensin-converting enzyme inhibition, but not AT(1) receptor blockade, in the solitary tract nucleus improves baroreflex sensitivity in anesthetized transgenic hypertensive (mRen2)27 rats.

Authors:  Katsunori Isa; Amy C Arnold; Brian M Westwood; Mark C Chappell; Debra I Diz
Journal:  Hypertens Res       Date:  2011-09-22       Impact factor: 3.872

Review 2.  Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.

Authors:  Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

3.  Determination of Angiotensin-(1-7) with HPLC/Fluorescence-Detection.

Authors:  Miriam Russ; Susanne Hauser; Reinhold Wintersteiger; Joachim Greilberger; Michaela Andrä; Astrid Ortner
Journal:  J Fluoresc       Date:  2015-10-09       Impact factor: 2.217

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

6.  Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7).

Authors:  Lucienne da Silva Lara; Fabíola Cavalcante; Flavia Axelband; Aloa Machado De Souza; Anibal Gil Lopes; Celso Caruso-Neves
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

7.  Evidence for a functional cardiac interaction between losartan and angiotensin-(1-7) receptors revealed by orthostatic tilting test in rats.

Authors:  Marina Matos de Moura; Robson Augusto Sousa dos Santos; Marco Antônio Peliky Fontes
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

8.  Simultaneous analysis of angiotensin peptides by LC-MS and LC-MS/MS: metabolism by bovine adrenal endothelial cells.

Authors:  Lijie Cui; Kasem Nithipatikom; William B Campbell
Journal:  Anal Biochem       Date:  2007-07-05       Impact factor: 3.365

9.  Gender differences in the effects of antenatal betamethasone exposure on renal function in adult sheep.

Authors:  Lijun Tang; Luke C Carey; Jianli Bi; Nancy Valego; Xiurong Sun; Philip Deibel; James Perrott; Jorge P Figueroa; Mark C Chappell; James C Rose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-11-26       Impact factor: 3.619

Review 10.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.